The company's devices use the patient's neural fingerprint to monitor and adapt the dose of electrical stimulation automatically, providing tailored therapy in real-time. Their first product, the Evoke System, is the only ECAP-controlled closed-loop spinal cord stimulation system indicated for the management of chronic intractable pain of the trunk and/or limbs. The Evoke System provides continually optimized therapy and is proven to be superior to open-loop SCS for the treatment of overall trunk and/or limb pain. The company has published double-blind randomized controlled trials in The Lancet Neurology and JAMA Neurology, setting new clinical standards for long-term pain relief and improvements in physical and emotional functioning, sleep quality, and health-related quality of life. Saluda Medical is headquartered in Australia and has offices in the US, UK, and Netherlands.